FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2047838628> ?p ?o ?g. }

• W2047838628 endingPage "810" @default.
• W2047838628 startingPage "805" @default.
• W2047838628 abstract "The aim of the present study was to determine the optimal time for concurrent thoracic radiotherapy (TRT) with etoposide and cisplatin̸carboplatin (EP̸EC) chemotherapy for the treatment of limited‑disease small‑cell lung cancer (LD SCLC). randomized controlled trials comparing early and late concurrent TRT with EP̸EC chemotherapy for the treatment of patients with LD SCLC were identified through searching databases such as MEDLINE, the Cochrane Central Register of Controlled Trials and Embase. Early thoracic radiotherapy (ERT) was defined as initiating irradiation within 30 days after chemotherapy initiation. A total of 3 eligible randomized controlled trials were identified. No significant differences in the objective response rate were detected between early and late concurrent TRT [risk ratio (RR)=1.01; 95% confidence interval (CI): 0.86‑1.18; P=0.90]. Similar results were observed in the 1‑, 2‑, 3‑ and 5‑year survival rates between early and late concurrent TRT (RR=1.06, 95% CI: 0.88‑1.27, P=0.56; RR=1.15, 95% CI: 0.77‑1.71, P=0.49; RR=0.90, 95% CI: 0.66‑1.22, P=0.49; and RR=1.18, 95% CI: 0.64‑2.16, P=0.60, respectively). the total incidence of grade 3‑4 adverse events, including anemia, leukopenia, neutropenia, thrombocytopenia, nausea and vomiting, infection, esophageal toxicity, pulmonary toxicity, alopecia and hemorrhage with early concurrent TRT was significantly higher compared to that with late concurrent TRT (RR=1.21, 95% CI: 1.03‑1.43, P=0.02). Thus, the results of our study indicated that the prognosis of LD SCLC treated with late concurrent TRT and EP̸EC chemotherapy is similar to that with early concurrent TRT, although the incidence of grade 3‑4 adverse events was lower in LD SCLC patients treated with late concurrent TRT combined with EP̸EC chemotherapy." @default.
• W2047838628 created "2016-06-24" @default.
• W2047838628 creator A5024914461 @default.
• W2047838628 creator A5030374112 @default.
• W2047838628 creator A5032205351 @default.
• W2047838628 creator A5066357381 @default.
• W2047838628 creator A5068284153 @default.
• W2047838628 date "2014-06-12" @default.
• W2047838628 modified "2023-10-16" @default.
• W2047838628 title "A meta-analysis of randomized controlled trials comparing early and late concurrent thoracic radiotherapy with etoposide and cisplatin/carboplatin chemotherapy for limited-disease small-cell lung cancer" @default.
• W2047838628 cites W1552379896 @default.
• W2047838628 cites W1885320430 @default.
• W2047838628 cites W1903188031 @default.
• W2047838628 cites W1905406155 @default.
• W2047838628 cites W1961685780 @default.
• W2047838628 cites W1965940143 @default.
• W2047838628 cites W1967655634 @default.
• W2047838628 cites W1976228473 @default.
• W2047838628 cites W1978074676 @default.
• W2047838628 cites W1981989535 @default.
• W2047838628 cites W1996661703 @default.
• W2047838628 cites W2026516286 @default.
• W2047838628 cites W2043103956 @default.
• W2047838628 cites W2067790939 @default.
• W2047838628 cites W2101156795 @default.
• W2047838628 cites W2107328434 @default.
• W2047838628 cites W2124353451 @default.
• W2047838628 cites W2125430981 @default.
• W2047838628 cites W2127093828 @default.
• W2047838628 cites W2131664752 @default.
• W2047838628 cites W2141539943 @default.
• W2047838628 cites W2150713507 @default.
• W2047838628 cites W2150878803 @default.
• W2047838628 cites W2160012348 @default.
• W2047838628 cites W2216166526 @default.
• W2047838628 cites W2256738179 @default.
• W2047838628 cites W2263690797 @default.
• W2047838628 doi "https://doi.org/10.3892/mco.2014.311" @default.
• W2047838628 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4106745" @default.
• W2047838628 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25054049" @default.
• W2047838628 hasPublicationYear "2014" @default.
• W2047838628 type Work @default.
• W2047838628 sameAs 2047838628 @default.
• W2047838628 citedByCount "14" @default.
• W2047838628 countsByYear W20478386282016 @default.
• W2047838628 countsByYear W20478386282017 @default.
• W2047838628 countsByYear W20478386282018 @default.
• W2047838628 countsByYear W20478386282019 @default.
• W2047838628 countsByYear W20478386282021 @default.
• W2047838628 countsByYear W20478386282022 @default.
• W2047838628 crossrefType "journal-article" @default.
• W2047838628 hasAuthorship W2047838628A5024914461 @default.
• W2047838628 hasAuthorship W2047838628A5030374112 @default.
• W2047838628 hasAuthorship W2047838628A5032205351 @default.
• W2047838628 hasAuthorship W2047838628A5066357381 @default.
• W2047838628 hasAuthorship W2047838628A5068284153 @default.
• W2047838628 hasBestOaLocation W20478386281 @default.
• W2047838628 hasConcept C126322002 @default.
• W2047838628 hasConcept C141071460 @default.
• W2047838628 hasConcept C143998085 @default.
• W2047838628 hasConcept C168563851 @default.
• W2047838628 hasConcept C207103383 @default.
• W2047838628 hasConcept C2776256026 @default.
• W2047838628 hasConcept C2776694085 @default.
• W2047838628 hasConcept C2777063308 @default.
• W2047838628 hasConcept C2778119113 @default.
• W2047838628 hasConcept C2778239845 @default.
• W2047838628 hasConcept C2780873365 @default.
• W2047838628 hasConcept C2781451048 @default.
• W2047838628 hasConcept C44249647 @default.
• W2047838628 hasConcept C509974204 @default.
• W2047838628 hasConcept C71924100 @default.
• W2047838628 hasConcept C82789193 @default.
• W2047838628 hasConcept C90924648 @default.
• W2047838628 hasConceptScore W2047838628C126322002 @default.
• W2047838628 hasConceptScore W2047838628C141071460 @default.
• W2047838628 hasConceptScore W2047838628C143998085 @default.
• W2047838628 hasConceptScore W2047838628C168563851 @default.
• W2047838628 hasConceptScore W2047838628C207103383 @default.
• W2047838628 hasConceptScore W2047838628C2776256026 @default.
• W2047838628 hasConceptScore W2047838628C2776694085 @default.
• W2047838628 hasConceptScore W2047838628C2777063308 @default.
• W2047838628 hasConceptScore W2047838628C2778119113 @default.
• W2047838628 hasConceptScore W2047838628C2778239845 @default.
• W2047838628 hasConceptScore W2047838628C2780873365 @default.
• W2047838628 hasConceptScore W2047838628C2781451048 @default.
• W2047838628 hasConceptScore W2047838628C44249647 @default.
• W2047838628 hasConceptScore W2047838628C509974204 @default.
• W2047838628 hasConceptScore W2047838628C71924100 @default.
• W2047838628 hasConceptScore W2047838628C82789193 @default.
• W2047838628 hasConceptScore W2047838628C90924648 @default.
• W2047838628 hasIssue "5" @default.
• W2047838628 hasLocation W20478386281 @default.
• W2047838628 hasLocation W20478386282 @default.
• W2047838628 hasLocation W20478386283 @default.
• W2047838628 hasLocation W20478386284 @default.
• W2047838628 hasOpenAccess W2047838628 @default.
• W2047838628 hasPrimaryLocation W20478386281 @default.

• next